FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study

NCT ID: NCT00619788

Last Updated: 2010-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This investigation is designed to demonstrate the efficacy and safety of the 4.0-5.0mm AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for femoropopliteal use in a controlled clinical investigation.

The scoring balloon is a semi-compliant balloon encircled by 3 spiral struts with a nitinol scoring element, which theoretically provides targeted scoring of lesions, by concentrating the dilation force thus minimizing barotrauma, elastic recoil and uncontrolled dissection. This may improve the outcome of the intervention and reduce the number of stents required.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Occlusive Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients receiving 4.0-5.0mm AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for femoropopliteal use

Group Type EXPERIMENTAL

4.0-5.0mm AngioSculpt Scoring Balloon Catheter

Intervention Type DEVICE

The AngioSculpt Scoring Balloon Catheter is a line of innovative angioplasty catheters comprising an angioplasty balloon surrounded by a unique system of nitinol scoring elements. Creating focal concentrations of dilating force, the scoring elements score arterial lesions as the balloon expands.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

4.0-5.0mm AngioSculpt Scoring Balloon Catheter

The AngioSculpt Scoring Balloon Catheter is a line of innovative angioplasty catheters comprising an angioplasty balloon surrounded by a unique system of nitinol scoring elements. Creating focal concentrations of dilating force, the scoring elements score arterial lesions as the balloon expands.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Stenotic (\>50%) or occlusive atherosclerotic disease of the femoropopliteal arteries (primarily superficial femoral arteries - SFA)
* Length of lesion \>5 cm or 2 times the AngioSculpt balloon length (whichever is longer)
* Reference vessel diameter should be 4.0-6.0 mm
* Life altering claudication or critical limb ischemia (Rutherford 3-5)
* No untreated inflow-limiting arterial lesions
* At least single vessel run-off until the ankle
* The patient must be \> 18 years.
* Life-expectancy of more than 12 months
* The subject or legal guardian has been informed of the nature of the evaluation; agrees to its provisions and has signed informed consent
* The patient is capable to follow all evaluation requirements.

Exclusion Criteria

* Patient refusing treatment
* The reference segment diameter is not suitable for available catheter design
* Length of lesion is ≥5 cm or requires more than two overlapping AngioSculpt balloon inflations (whichever is longer) to cover the entire lesion (however, more than two inflations are permitted within an acceptable lesion length)
* The patient has a known allergy to heparin, aspirin or other anticoagulant/antiplatelet therapies or a bleeding diatheses or is unable, or unwilling, to tolerate such therapies
* The patient has a history of prior life-threatening contrast media reaction
* The patient is currently enrolled in another investigational device or drug trial
* The patient is currently breast-feeding, pregnant or intends to become pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AngioScore, Inc.

INDUSTRY

Sponsor Role collaborator

Flanders Medical Research Program

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Flanders Medical Research Program

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrick Peeters, MD

Role: PRINCIPAL_INVESTIGATOR

Imelda Hospital, Bonheiden, Belgium

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imelda Hospital

Bonheiden, , Belgium

Site Status

AZ St-Blasius

Dendermonde, , Belgium

Site Status

Herzzentrum

Leipzig, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMRP-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stellarex Vascular E-Registry
NCT02769273 COMPLETED